- Condition: Stroke
Interventions: Behavioral: Usual care; Behavioral: Overground visual cue training; Behavioral: Treadmill visual cue training
Sponsors: University of Salford; University of Salford; University of Birmingham; Nottingham Clinical Trials Unit; Stroke Research Network; The University of Newcastle, Australia
Not yet recruiting - verified May 2012 - Condition: Stroke
Interventions: Other: Treadmill belts of dual-belt treadmill respond to encourage symmetric gait; Other: Treadmill belts of dual-belt treadmill respond to amplify asymmetric gait; Other: No difference in treadmill belt speeds
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: Morbid Obesity
Interventions: Drug: Ephedrine sulfate with caffeine; Drug: cellulose
Sponsors: Oregon Weight Loss Surgery, LLC; Oregon Weight Loss Surgery, LLC
Not yet recruiting - verified May 2012 - Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate; Drug: Long acting methylphenidate; Drug: Matched placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified May 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: PLX3397; Drug: Eribulin
Sponsors: University of California, San Francisco; Hope Rugo, MD; Susan G. Komen Breast Cancer Foundation; Plexxikon, Inc.; Eisai Inc.
Not yet recruiting - verified May 2012 - Condition: Periodontal Disease
Intervention: Other: Specimens collection
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Not yet recruiting - verified May 2012 - Conditions: WorkStation Intervention; Usual Working Condition
Interventions: Behavioral: WorkStation; Behavioral: Usual Working Condition
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center; Blue Cross Blue Shield
Recruiting - verified April 2012 - A Repeated Instruction by Telephone on the Day Before Colonoscopy to Patients Undergoing ColonoscopyConditions: Bowel Preparation Score; Adenoma
Intervention: Other: telephone education
Sponsors: Fourth Military Medical University; Fourth Military Medical University
Recruiting - verified April 2012 - Condition: Dental and Occlusal Stability
Interventions: Device: Essix retainer; Device: Hawley retainer
Sponsors: CES University; CES University; Universidad de Antioquia
Recruiting - verified April 2012 - Condition: Fusion of Spine, Lumbar Region
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified April 2012 - Conditions: Liver Cancer; Pancreatic Cancer
Interventions: Drug: FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin); Device: TheraSpheres
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Nordion (Canada) Inc.
Recruiting - verified April 2012 - Condition: Osteoarthritis
Interventions: Other: Hospital Inpatient Rehabilitation; Other: Hybrid Home Programme (HO)
Sponsors: South West Sydney Local Health District; Mark Buhagiar; HammondCare
Not yet recruiting - verified April 2012 - Condition: Depression
Intervention: Drug: Escitalopram
Sponsors: Beitou Armed Forces Hospital, Taipei, Taiwan; Beitou Armed Forces Hospital, Taipei, Taiwan
Recruiting - verified May 2012 - Conditions: Back Pain; Osteoarthritis
Interventions: Other: Opioid-intensive prescribing strategy; Other: Opioid-avoidant prescribing strategy
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Condition: Ovarian Cancer
Interventions: Drug: vargatef; Drug: placebo
Sponsors: ARCAGY/ GINECO GROUP; ARCAGY/ GINECO GROUP
Not yet recruiting - verified April 2012 - Condition: Severe Sepsis
Interventions: Drug: Vitamin C; Drug: placebo
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Conditions: Age-Related Maculopathy; Age-Related Maculopathies; Eye Diseases; Retinal Degeneration; Macular Degeneration
Interventions: Biological: RN6G; Biological: Placebo
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Condition: Methamphetamine Dependence
Intervention: Behavioral: Text messages
Sponsors: New Leaf Treatment Center; New Leaf Treatment Center
Recruiting - verified April 2012 - Condition: Stroke
Interventions: Drug: Tissue Plasminogen Activator (Alteplase); Drug: Placebo
Sponsors: National Stroke Research Institute, Australia; National Stroke Research Institute, Australia; China Medical University Hospital
Not yet recruiting - verified April 2012 - Condition: Monckeberg Medial Calcific Sclerosis
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified April 2012 - Conditions: Bloodstream Infections; Short Bowel Syndrome; Development; Nutrition; Biological Markers
Interventions: Drug: Glutamine; Dietary Supplement: L-alanine
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emmaus Medical, Inc.; University of Michigan; Emory University; University of Colorado, Denver
Recruiting - verified April 2012 - Conditions: Stroke; Hemiparesis
Interventions: Behavioral: Usual Care; Behavioral: FAST protocol
Sponsors: University of British Columbia; University of British Columbia; Heart and Stroke Foundation of Canada
Not yet recruiting - verified April 2012 - Condition: Meniscectomy
Interventions: Behavioral: Therapy; Behavioral: Exercise therapy
Sponsors: University Hospital, Ghent; University Hospital, Ghent
Not yet recruiting - verified April 2012 - Condition: Bullous Pemphigoid
Intervention: Drug: DF2156A
Sponsors: Dompé s.p.a.; Dompé s.p.a.
Recruiting - verified April 2012 - Condition: Stroke
Intervention: Behavioral: Gait training
Sponsors: Northeastern University; Northeastern University; Rosalind Franklin University of Medicine and Science; New England Rehabilitation Hospital
Recruiting - verified March 2012 - Condition: Intubation Condtions
Interventions: Drug: Magnésium sulphate; Drug: Curarisation with rocuronium; Drug: Perfusion of Placebo; Drug: Succinylcholine
Sponsors: University Hospital, Geneva; University Hospital, Geneva; University of Lausanne Hospitals
Not yet recruiting - verified February 2012 - Condition: Neuromuscular Disorders
Interventions: Procedure: Different motor function tests; Procedure: Manual dexterity assessment
Sponsors: Institut de Myologie, France; Institut de Myologie, France
Recruiting - verified March 2012 - Condition: Identify Normal MII-pH Parameters
Intervention: Procedure: 24-hr pH monitoring
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified March 2012 - Condition: Multiple Sclerosis
Interventions: Drug: Prolonged-release Fampridine; Drug: Placebo
Sponsors: University of Zurich; University of Zurich
Recruiting - verified March 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: Atomoxetine; Drug: placebo
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Mucositis
Intervention: Drug: Ketamine
Sponsors: West Virginia University; Aaron Cumpston, PharmD
Recruiting - verified March 2012 - Condition: Cardiovascular Disease
Interventions: Behavioral: Tai Chi exercise; Behavioral: Sham Exercise
Sponsors: McMaster University; McMaster University; Heart and Stroke Foundation of Ontario; Hamilton Health Sciences Corporation
Recruiting - verified May 2012 - Conditions: Heart Failure NYHA Class III; Heart Failure NYHA Class II
Interventions: Behavioral: High-intensity IMT plus walking; Behavioral: Low-intensity IMT plus walking
Sponsors: Texas Woman's University; Texas Woman's University
Recruiting - verified March 2012 - Condition: Prostate Carcinoma
Interventions: Drug: Metformin; Drug: Simvastatin
Sponsors: Baylor College of Medicine; Nicholas Mitsiades
Recruiting - verified March 2012 - Condition: Hidradenitis Suppurativa
Interventions: Drug: Water for injection; Drug: Anakinra
Sponsors: University of Athens; University of Athens
Recruiting - verified March 2012 - Conditions: Hypertension; Stroke
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Conditions: Uveitis Related Cystoid Macular Edema; Steroid-induced Glaucoma - Borderline
Intervention: Drug: Ranibizumab
Sponsors: Moorfields Eye Hospital NHS Foundation Trust; Moorfields Eye Hospital NHS Foundation Trust; Novartis
Recruiting - verified March 2012 - Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Device: Gait trainer; Other: Control treatment
Sponsors: Universita di Verona; Universita di Verona
Recruiting - verified April 2012 - Condition: Red Blood Cell Folate
Interventions: Dietary Supplement: Folic acid; Dietary Supplement: L-5-MTHF; Other: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified March 2012 - Condition: Implants
Intervention:
Sponsors: GE Healthcare; GE Healthcare
Recruiting - verified April 2012 - Conditions: GERD; Esophagitis
Intervention: Procedure: Standard of care endoscopy
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified March 2012 - Conditions: Nocturnal Hypokinesia; Parkinsons's Disease; Rotigotine
Intervention:
Sponsors: Sleep Medicine Centre Kempenhaeghe; Sleep Medicine Centre Kempenhaeghe
Recruiting - verified March 2012 - Condition: Stroke
Intervention: Device: Tibion Bionic Leg
Sponsors: Tibion Bionics, Inc.; Tibion Bionics, Inc.
Recruiting - verified March 2012 - Conditions: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Interventions: Drug: Placebo; Drug: Varenicline; Drug: Varenicline
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Conditions: Mild Cognitive Impairment; Mild Alzheimer's Disease
Interventions: Drug: AZD5213; Drug: AZD5213; Drug: AZD5213; Other: Placebo
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified March 2012 - Condition: Traumatic Amputation of Arm
Intervention: Other: Socket
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Lifespan; Brown University
Recruiting - verified April 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Delayed Circadian Rhythm Disorder
Intervention: Device: Polarized glasses designed to filter out blue light
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified March 2012 - Conditions: Macular Edema; Central Retinal Vein Occlusion
Intervention: Drug: Ranibizumab 0.5 mg/0.05 ml, intravitreal injection
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified March 2012 - Condition: Critical Illness
Interventions: Other: mobilization; Other: mobilization
Sponsors: Region Sealand; Region Sealand; Capital Region
Recruiting - verified March 2012 - Condition: Disability
Intervention: Behavioral: Aerobic exercise
Sponsors: University of Florida; University of Florida
Not yet recruiting - verified February 2012 - Condition: Methamphetamine Metabolism, CYP2D6 Genotype
Intervention: Drug: A single oral 5 mg of duterium labeled methamphetamine
Sponsors: California Pacific Medical Center Research Institute; California Pacific Medical Center Research Institute; The Children's Mercy Hospital
Not yet recruiting - verified October 2009 - Condition: Skeletal Muscle
Interventions: Drug: BYM338; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Conditions: Underdosing of Skeletal Muscle Relaxants for Laparotomy; Reversal of Skeletal Muscle Relaxant
Interventions: Drug: Neostigmine, atropine; Drug: Sugammadex
Sponsors: Hospital Sultanah Aminah Johor Bahru; Hospital Sultanah Aminah Johor Bahru
Not yet recruiting - verified February 2012 - Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung DiseaseConditions: Chronic Lung Disease; Self-efficacy
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Condition: Unilateral Knee Osteoarthritis
Intervention: Other: Exercise in eccentric or concentric mode
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand
Not yet recruiting - verified April 2012 - Condition: Acute Myelogenous Leukemia
Intervention: Device: 3T Siemens TIM Trio whole-body system
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute
Recruiting - verified April 2012 - Condition: Irritable Bowel Syndrome
Intervention:
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified February 2012 - Condition: The Focus of This Study is to Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration.
Interventions: Drug: Atropine; Drug: Placebo
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen; University of Copenhagen
Recruiting - verified February 2012 - Condition: Hepatocellular Carcinoma
Intervention:
Sponsors: Kaohsiung Medical University Chung-Ho Memorial Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Department of Health, Taiwan
Recruiting - verified April 2010 - Condition: Platelet Rich Plasma Production
Intervention: Procedure: Venipuncture
Sponsors: Peterson, Noel, N.D.; Peterson, Noel, N.D.
Recruiting - verified March 2012 - Conditions: Transfemoral Amputation; Unilateral Traumatic Amputation of Leg at or Above Knee
Interventions: Device: C leg compared to subject's mechanical leg (Otto Bock); Device: C leg compared to subject's mechanical leg (Otto Bock)
Sponsors: Rehabilitation Institute of Chicago; Rehabilitation Institute of Chicago; Otto Bock Healthcare
Recruiting - verified February 2012 - Condition: Cornea Tissue Preservation Time
Intervention: Biological: Cornea tissue transplant
Sponsors: Case Western Reserve University; Case Western Reserve University; National Eye Institute (NEI); Jaeb Center for Health Research
Recruiting - verified May 2012 - Condition: Actinic Keratosis
Interventions: Procedure: Cryotherapy; Drug: Vehicle; Drug: Ingenol metabute
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified March 2012 - Condition: Pregnancy Prevention
Intervention: Behavioral: Teen Outreach Program with Media Enhancement (TOP4ME)
Sponsors: Colorado School of Public Health; Colorado School of Public Health; Denver Health and Hospital Authority
Recruiting - verified December 2011 - Condition: Cerebrovascular Accident
Interventions: Behavioral: Task-related unilateral arm training; Behavioral: Task-related bilateral arm training; Behavioral: Combined uni- and bi-lateral arm training; Device: Robot-assisted bilateral arm training; Device: Robot-assisted unilateral arm training
Sponsors: Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Science Council, Taiwan; National Health Research Institutes, Taiwan
Recruiting - verified January 2012 - Condition: Percutaneous Tracheostomy
Intervention: Procedure: Percutaneous tracheostomy
Sponsors: University of Alberta; University of Alberta
Recruiting - verified January 2012 - Conditions: Depression; Substance Abuse; Substance Use
Intervention: Drug: Creatine monohydrate
Sponsors: University of Utah; Perry Renshaw
Recruiting - verified April 2012 - Conditions: Head Neck Cancer Squamous Cell Metastatic; Head Neck Cancer Squamous Cell Recurrent
Intervention: Drug: BKM120
Sponsors: Yonsei University; Yonsei University
Not yet recruiting - verified February 2012 - Condition: Hyperopia
Intervention: Procedure: Glasses
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified April 2012 - Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy; Procedure: Near target push-ups; Other: Placebo home-based computer vergence/accommodative therapy; Procedure: Placebo yoked prism flippers
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Not yet recruiting - verified January 2012 - Condition: Tophaceous Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified March 2012 - Conditions: Sepsis; Inflammation; Shock
Intervention:
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; The Physicians' Services Incorporated Foundation
Not yet recruiting - verified February 2012 - Condition: Mild Cognitive Decline
Interventions: Dietary Supplement: Freeze-dried blueberries; Dietary Supplement: Dextrose Placebo
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Not yet recruiting - verified January 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Bronchitis, Chronic; Pulmonary Emphysema; Disease Progression
Intervention:
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council; The Hillingdon Hospitals NHS Foundation Trust; West Hertfordshire Hospitals NHS Trust
Recruiting - verified January 2012 - Conditions: Postmenopausal Disorder; Blood Pressure; Over Weight
Interventions: Behavioral: Basic Intervention; Behavioral: Enhanced Pedometry; Behavioral: Control Group
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center; American Heart Association
Recruiting - verified January 2012 - Condition: Healthy
Intervention: Other: Different walk tests with an accelerometer device
Sponsors: Institut de Myologie, France; Institut de Myologie, France
Recruiting - verified January 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive; Pulmonary Emphysema; Bronchitis, Chronic; Lung Diseases; Disease Progression
Intervention:
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council
Recruiting - verified January 2012 - Condition: Psoriasis
Intervention: Drug: Ustekinumab
Sponsors: University of California, San Francisco; University of California, San Francisco
Not yet recruiting - verified January 2012 - Condition: Gastro-oesophageal Reflux Disease
Intervention:
Sponsors: Imperial College London; Imperial College London
Not yet recruiting - verified January 2012 - Conditions: Insomnia; Nocturnal Awakening; Irritability; Coping Behavior; Stress
Interventions: Dietary Supplement: 5-Aminolevulinic Acid (5-ALA); Dietary Supplement: Placebo
Sponsors: University of Hawaii; University of Hawaii; SBI ALApromo Co., Ltd. - Strategic Business Innovator
Recruiting - verified February 2012 - Condition: Endometrial Polyps
Interventions: Device: hysteroscopic morcellator (TruClear); Device: Bipolar Electrical resectoscope (Versapoint)
Sponsors: Birmingham Women's NHS Foundation Trust; Birmingham Women's NHS Foundation Trust; Smith & Nephew, Inc.
Not yet recruiting - verified January 2012 - Condition: Head and Neck Cancer
Interventions: Other: Progressive Resistance Exercise Training; Other: Progressive Resistance Exercise Training
Sponsors: Danish Head and Neck Cancer Group; Danish Head and Neck Cancer Group
Recruiting - verified January 2012 - Condition: Age Related Macular Degeneration (ARMD)
Interventions: Behavioral: Supervised Reading; Behavioral: EVT at the PRL; Behavioral: EVT at the TRL
Sponsors: Moorfields Eye Hospital NHS Foundation Trust; Moorfields Eye Hospital NHS Foundation Trust; British Eye Research Foundation, operating as Fight for Sight
Recruiting - verified December 2011 - Condition: Healthy Volunteers
Interventions: Drug: Levocetirizine; Drug: Hydroxyzine; Drug: Placebo
Sponsors: Utrecht Institute for Pharmaceutical Sciences; Utrecht Institute for Pharmaceutical Sciences; Royal Netherlands Navy
Not yet recruiting - verified December 2011 - Condition: Neck Pain
Interventions: Procedure: cupping massage; Procedure: Progressive muscle relaxation
Sponsors: Universität Duisburg-Essen; Universität Duisburg-Essen
Recruiting - verified February 2012 - Condition: Total Knee Arthroplasty
Interventions: Drug: naropin; Drug: marcaine; Drug: sufentanil; Drug: neurontin
Sponsors: St. Antonius Hospital; St. Antonius Hospital
Not yet recruiting - verified December 2011 - Conditions: Magnetic Resonance Spectroscopy; Ethanol; Spectroscopy
Intervention: Drug: Alcohol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified November 2011 - Condition: Maternal Infection Affecting Newborn
Intervention: Other: Screening treatment and referral
Sponsors: Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Bloomberg School of Public Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); United States Agency for International Development (USAID)
Recruiting - verified December 2011 - Condition: Psychosis
Interventions: Behavioral: Cognitive Remediation; Behavioral: Supported Education
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health; George Brown College
Recruiting - verified February 2012 - Condition: Hidradenitis Suppurativa
Intervention: Drug: anakinra
Sponsors: University of California, San Francisco; University of California, San Francisco
Not yet recruiting - verified March 2012 - Conditions: Non Alcoholic Fatty Liver Disease; Type 2 Diabetes; Liver Cirrhosis
Interventions: Other: OGTT; Other: IIGI
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified December 2011 - Conditions: Amyotrophic Lateral Sclerosis; Nervous System Diseases; Sclerosis; Motor Neuron Disease; Spinal Cord Diseases; Central Nervous System Diseases; Neurodegenerative Diseases; Neuromuscular Diseases; ALS
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; ALS Therapy Alliance
Recruiting - verified April 2012 - Condition: Diabetic Macular Edema
Intervention: Drug: Macugen (Pegaptanib Sodium)
Sponsors: Retina Institute of Hawaii; Retina Institute of Hawaii; Eyetech Pharmaceuticals
Available - verified December 2011 - Condition: Cocaine Dependence
Intervention: Drug: Lisdexamfetamine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Lung Adenocarcinoma
Intervention: Other: CT, PET, copy number alteration
Sponsors: Samsung Medical Center; Samsung Medical Center; Korean Foundation for Cancer Research
Recruiting - verified November 2011 - Condition: Substance Abuse
Intervention: Other: STaRS
Sponsors: Polaris Health Directions; Polaris Health Directions; University of Massachusetts, Worcester
Not yet recruiting - verified December 2011 - Condition: Knee Osteoarthritis
Interventions: Device: double leg press with partial blood flow restriction; Other: double leg press without partial blood flow restriction
Sponsors: University of Iowa; University of Iowa
Recruiting - verified December 2011 - Condition: Postpartum Depression
Intervention: Behavioral: Interpersonal therapy-based treatment
Sponsors: Women and Infants Hospital of Rhode Island; Women and Infants Hospital of Rhode Island; National Institute of Mental Health (NIMH); Pacific Institute for Research and Evaluation; Brown University
Recruiting - verified January 2012 - Condition: Schizophrenia
Interventions: Drug: TC-5619 5mg; Drug: TC-5619 50mg; Drug: Placebo
Sponsors: Targacept Inc.; Targacept Inc.
Recruiting - verified May 2012 - Conditions: Age-related Bone Loss; Age Related Muscle Loss; Falls; Fractures
Interventions: Dietary Supplement: potassium bicarbonate; Dietary Supplement: potassium bicarbonate; Other: placebo
Sponsors: Tufts University; Tufts University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Conditions: Type 2 Diabetes; Hypertension
Interventions: Behavioral: Step count prescription; Behavioral: Usual care
Sponsors: McGill University Health Center; McGill University Health Center; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Acne
Interventions: Drug: Epiduo/Tactuo + doxycycline 200mg; Drug: Isotretinoin + vehicle gel
Sponsors: Galderma; Galderma
Recruiting - verified March 2012 - Condition: HER2 Negative Breast Cancer
Interventions: Biological: NeuVax vaccine; Biological: Leukine (sargramostim, GM-CSF) and water for injection
Sponsors: Galena Biopharma, Inc.; Galena Biopharma, Inc.
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Interventions: Behavioral: Task-oriented circuit class training; Behavioral: usual care
Sponsors: University Hospital of Ferrara; University Hospital of Ferrara; Simonetta Masnada, PT; Michela Bonato, PT; Amira Sabbagh Charabati, PT; Eleonora Zancato, PT
Recruiting - verified November 2011 - Condition: Infection
Intervention: Device: STD Diagnostic Kit (Identigene)
Sponsors: Identigene; Identigene; Lifetree Clinical Research
Recruiting - verified November 2011 - Condition: Colorectal Cancer, Metastatic
Interventions: Other: Pharmacokinetic 5-FU dose adjustment using OnDose® assay; Other: Standard of care
Sponsors: Myriad Genetic Laboratories, Inc.; Myriad Genetic Laboratories, Inc.
Recruiting - verified February 2012 - Condition: Neuroblastoma Recurrent
Interventions: Drug: Dasatinib; Drug: Rapamycin; Drug: Irinotecan; Drug: Temozolomide; Drug: Irinotecan; Drug: Temozolomide
Sponsors: University of Regensburg; University of Regensburg
Not yet recruiting - verified November 2011 - Condition: Cutaneous Leishmaniasis
Interventions: Drug: meglumine antimonate; Drug: Placebo; Drug: Pentoxifylline
Sponsors: Centro Internacional de Entrenamiento e Investigaciones Médicas; Centro Internacional de Entrenamiento e Investigaciones Médicas
Not yet recruiting - verified November 2011 - Condition: Chronic Kidney Disease
Interventions: Behavioral: Aerobic exercise training; Behavioral: Health Education
Sponsors: University of Maryland; University of Maryland; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Acute Lymphoid Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Multiple Myeloma; Solid Tumors
Intervention: Drug: brentuximab vedotin
Sponsors: Seattle Genetics, Inc.; Seattle Genetics, Inc.
Recruiting - verified April 2012 - Conditions: Lipofilling; Human Autologous Fat Transfer
Interventions: Biological: Addition of PRP ( platelet rich plasma) to the lipograft; Procedure: Lipofilling of the midface
Sponsors: Bergman Clinics; Bergman Clinics; Biomet, Inc.
Not yet recruiting - verified October 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Training and liraglutide; Drug: Training and placebo; Drug: Liraglutide
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified September 2011 - Condition: Coronary Artery Disease
Interventions: Other: CT coronary angiography; Other: Standard of Care
Sponsors: Wellington Hospital; AJAY YERRAMASU; Wellington Hospital, London, UK; Barnet Hospital, Wellhouse Lane, Barnet, EN5 3DJ, UK; Chase Farm Hospital, The Ridgeway, Enfield, EN2 8JL, UK; Royal Free Hospital, Pond Street, London, NW3 2QG, UK
Recruiting - verified October 2011 - Condition: Amphetamine-Related Disorders
Interventions: Drug: extended-release naltrexone; Drug: Placebo
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA); Alkermes
Not yet recruiting - verified October 2011 - Conditions: Chronic Kidney Disease; Metabolic Acidosis
Interventions: Drug: Sodium bicarbonate; Drug: Placebo
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH)
Recruiting - verified October 2011 - Conditions: Colon Carcinoma; Rectum Carcinoma
Interventions: Biological: L-BLP25; Biological: Placebo
Sponsors: Johannes Gutenberg University Mainz; Dr. Carl Schimanski
Recruiting - verified April 2012 - Conditions: Prematurity; Bronchopulmonary Dysplasia; Chronic Lung Disease of Prematurity
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2011 - Condition: Obesity
Interventions: Other: Dance Therapy; Other: patient education
Sponsors: University Hospital, Geneva; University Hospital, Geneva; University of Applied Sciences of Western Switzerland
Recruiting - verified October 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Amphetamine-dextroamphetamine (AMPH); Drug: Placebo; Behavioral: Well-being therapy
Sponsors: Massachusetts General Hospital; David P. Soskin,M.D.; Harvard University
Recruiting - verified March 2012 - Condition: Heart Disease
Intervention: Device: Anastomosis (C-Port® )
Sponsors: Cardica, Inc; Cardica, Inc
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: Certolizumab pegol
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Osteoarthritis
Interventions: Behavioral: GUIDED IMAGERY; Behavioral: PLACEBO
Sponsors: Kent State University; Kent State University; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified December 2011 - Condition: Degenerative Disk Disease
Interventions: Device: 4 CIS one-touch titanium cage; Device: Bonglass-SS SSLPB
Sponsors: BioAlpha Inc.; BioAlpha Inc.
Recruiting - verified September 2011 - Conditions: Brain Metastasis; Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified November 2011 - Conditions: Esophageal Cancer; Stomach Cancer; Pancreatic Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Very Low Birth Weight Infants
Interventions: Other: application of mother's own colostrum; Other: application of sterile water
Sponsors: Milton S. Hershey Medical Center; Milton S. Hershey Medical Center; Children's Miracle Network
Recruiting - verified September 2011 - Conditions: Sarcoma; Wilm's Tumor; Lymphoma; Neuroblastoma
Intervention: Drug: Ipilimumab(anti-CTLA-4 antibody)
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Multiple Sclerosis; Fatigue
Interventions: Drug: Dalfampridine; Drug: Placebo
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Acorda Therapeutics
Recruiting - verified October 2011 - Condition: Post Menopausal
Interventions: Behavioral: videodance; Behavioral: Brisk Walking; Behavioral: delayed entry control
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute on Aging (NIA)
Recruiting - verified September 2011 - Condition: Peripheral Vestibular Disease
Intervention: Other: Vestibular Rehabilitation
Sponsors: Royal College of Surgeons, Ireland; Royal College of Surgeons, Ireland; Beaumont Hospital; Emory University; Royal Victoria Eye and Ear Hospital
Recruiting - verified September 2011 - Condition: Anaesthesia
Intervention: Other: Sedation depth
Sponsors: Melbourne Health; Melbourne Health
Recruiting - verified October 2011 - Conditions: Advanced Solid Tumors; Metastatic Breast Cancer; Metastatic Renal Cell Carcinoma
Intervention: Drug: RAD001 + BEZ235
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Interventions: Behavioral: Lokomat (Hocoma, Switzerland); Behavioral: Conventional Therapy
Sponsors: University Hospital of Ferrara; University Hospital of Ferrara; Azienda Ospedaliero, Universitaria Pisana
Recruiting - verified September 2011 - Condition: Renal Failure
Intervention: Device: 2008 Sorbent System
Sponsors: Renal Research Institute; Renal Research Institute; Renal Solutions, Inc.
Recruiting - verified September 2011 - Condition: Solid Tumors
Interventions: Drug: MM-121 (SAR256212) plus Gemcitabine; Drug: MM-121 (SAR256212) plus Carboplatin; Drug: MM-121 (SAR256212) plus Pemetrexed; Drug: MM-121 (SAR256212) plus Cabazitaxel
Sponsors: Merrimack Pharmaceuticals; Merrimack Pharmaceuticals; Sanofi-Aventis US, Inc.
Recruiting - verified January 2012 - Conditions: Schizophrenia; Schizophreniform Disorder; Schizoaffective Disorder
Intervention: Drug: Amisulpride
Sponsors: University of Copenhagen; Birte Glenthoj; Glostrup University Hospital, Copenhagen; Rigshospitalet, Denmark; Institute of Psychiatry, London; UMC Utrecht; Copenhagen Hospital Corporation
Recruiting - verified March 2012 - Condition: Peripheral Arterial Disease
Intervention: Behavioral: Supervised exercise Program
Sponsors: Dallas VA Medical Center; American Heart Association
Recruiting - verified September 2011 - Condition: Mechanical Low Back Pain
Interventions: Procedure: Thrust manipulation; Procedure: Non-thrust manipulation
Sponsors: Walsh University; Walsh University
Recruiting - verified September 2011 - Condition: COPD Exacerbation
Interventions: Drug: ceftidoren; Drug: levofloxacin
Sponsors: University of Milan; University of Milan
Recruiting - verified February 2012 - Condition: Spinal Stenosis
Intervention:
Sponsors: Rachiotek LLC; Rachiotek LLC
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate ); Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate ); Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Conditions: Alzheimer Disease; Depression
Intervention: Other: Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam
Sponsors: Centre Hospitalier Universitaire de Besancon; Pr Pierre Vandel; Psychology laboratory of Besançon EA 3188; Centre Hospitalier Universitaire Dijon; Hospital of Novillars; funding by French Hospital Progeram of Clinical Research (PHRC 2009-A00942-55)
Recruiting - verified September 2011 - Condition: Pulmonary Lesions
Intervention: Procedure: cryotherapy or radiofrequency ablation
Sponsors: Dongfang Hospital; Dongfang Hospital
Recruiting - verified September 2011 - Conditions: Heart Failure; Cardiomyopathy; Ventricular Dysfunction
Interventions: Biological: Mesenchymal Precursor Cell Injection; Biological: 50% Alpha-MEM/42.5% ProFreeze NAO Freezing Medium/7.5% DMSO
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Schizophrenia
Interventions: Drug: Lurasidone; Drug: Matching Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Conditions: Cerebral Palsy; Poststroke/CVA Paresis
Interventions: Device: Chaotic Perturbation; Device: Dummy not active shoes; Device: Treadmill training
Sponsors: Assaf-Harofeh Medical Center; Assaf-Harofeh Medical Center
Recruiting - verified November 2011 - Condition: Mood Swings
Interventions: Other: Nutrition; Behavioral: mood manipulation
Sponsors: TNO Quality of Life; TNO Quality of Life
Not yet recruiting - verified August 2011 - Conditions: Premature Birth; Placenta Previa
Interventions: Procedure: Placement of a Cervical Cerclage; Procedure: Standard Expectant Management
Sponsors: Obstetrix Medical Group; Obstetrix Medical Group
Recruiting - verified March 2012 - Condition: Parkinson's Disease
Interventions: Other: experimental; Other: control
Sponsors: The Hong Kong Polytechnic University; The Hong Kong Polytechnic University
Recruiting - verified August 2011 - Condition: Jaundice, Neonatal
Intervention: Procedure: Window tinting film for filtered sunlight phototherapy
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Thrasher Research Fund
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 20 mg
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Conditions: Traumatic Brain Injury; Walking Impairment; Gait Training
Intervention: Other: Gait Training Method
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified March 2012 - Conditions: MeSH Heading Cardiac Surgical Procedures; Tree Number E04.100.376; Tree Number E04.928.220
Intervention: Procedure: Heart Lung machine
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Not yet recruiting - verified August 2011 - Condition: Cystic Fibrosis
Interventions: Dietary Supplement: Glycine; Dietary Supplement: Placebo
Sponsors: Instituto Nacional de Enfermedades Respiratorias; Instituto Nacional de Enfermedades Respiratorias; Hospital Infantil de Mexico Federico Gomez; Instituto Mexicano del Seguro Social
Recruiting - verified March 2012 - Condition: Rotator Cuff Tendinopathy
Intervention: Behavioral: Eccentric exercise
Sponsors: University Ghent; University Ghent; Fund for Scientific Research, Flanders, Belgium
Not yet recruiting - verified April 2012 - Condition: Breast Neoplasms
Interventions: Other: Volume of Exercise; Moderate or High Volume; Other: Aerobic Exercise; Other: Aerobic Exercise
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified September 2011 - Condition: Neurofibromatosis Type II
Intervention: Drug: Everolimus (RAD001) , Afinitor®
Sponsors: New York University School of Medicine; New York University School of Medicine; Novartis Pharmaceuticals; The Children's Tumor Foundation
Recruiting - verified January 2012 - Condition: Hysterical Simulation of Disease
Interventions: Device: Functional electrical stimulator; Device: feet orthosis
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified July 2011 - Conditions: Angina Pectoris; Coronary Artery Disease; Type 2 Diabetes Mellitus
Intervention: Drug: Ranolazine
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
Interventions: Biological: DPX-Survivac; Drug: low dose cyclophosphamide (oral)
Sponsors: ImmunoVaccine Technologies, Inc.; ImmunoVaccine Technologies, Inc.
Recruiting - verified December 2011 - Conditions: Heart Failure; Atrial Fibrillation
Interventions: Procedure: Catheter ablation-based AF rhythm control; Drug: Medication Rate Control
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Conditions: Obesity; Phentermine Withdrawal
Intervention: Drug: Abrupt cessation of phentermine pharmacotherapy
Sponsors: Center for Weight Management, California; Center for Weight Management, California; American Society of Bariatric Physicians
Recruiting - verified August 2011 - Condition: Postmenopausal Osteoporosis
Intervention: Other: Observation
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; Sheffield Teaching Hospitals NHS Foundation Trust; NIHR Biomedical Research Unit for Musculoskeletal Disease
Recruiting - verified August 2011 - Condition: Epilepsy, Partial Onset Seizures
Intervention: Drug: Levetiracetam
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified March 2012 - Condition: Multiple Sclerosis
Intervention:
Sponsors: Mount Sinai Rehabilitation Hospital; Mount Sinai Rehabilitation Hospital; Brown University
Recruiting - verified July 2011 - Condition: Traumatic and/or Non-traumatic Brain Injury
Intervention:
Sponsors: Sheba Medical Center; Sheba Medical Center
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Intervention:
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Depression
Interventions: Behavioral: Deprexis; Behavioral: Wait-list
Sponsors: Universitätsklinikum Hamburg-Eppendorf; Universitätsklinikum Hamburg-Eppendorf
Recruiting - verified July 2011 - Condition: Acute Kidney Injury
Intervention: Device: SCD
Sponsors: CytoPherx, Inc; CytoPherx, Inc
Recruiting - verified March 2012 - Conditions: Depression; Depressive Disorder; Depressive Disorder, Major
Interventions: Drug: Buprenorphine; Drug: Placebo
Sponsors: University of Pittsburgh; University of Pittsburgh; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified January 2012 - Conditions: HIV; Sexually Transmitted Infections
Interventions: Behavioral: Connect 'n Unite; Behavioral: Wellness Promotion
Sponsors: Columbia University; Columbia University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2012 - Condition: Post and Core Failure
Interventions: Procedure: fiber post and resin core - self-adhesive cement; Procedure: cast post and core; Procedure: fiber post luted with conventional resin cement
Sponsors: Federal University of Pelotas; Federal University of Pelotas; Universidade Federal de Santa Maria
Recruiting - verified October 2011 - Condition: Left Ventricular Dyssynchrony
Intervention: Device: 3D Blood-Pool Gated SPECT (BPGS) with a new designed cardiac imaging camera (DSPECT, Spectrum Dynamics®, Ceasaria, Israel)
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand; Centre Jean Perrin
Recruiting - verified July 2011 - Conditions: HIV; Drug Addiction
Interventions: Behavioral: Psycho-education; Behavioral: Experimental
Sponsors: RTI International; RTI International; University of Cape Town
Recruiting - verified December 2011 - Conditions: Colorectal Neoplasms; Digestive System Diseases; Colonic Diseases; Colorectal Cancer
Intervention:
Sponsors: Exact Sciences Corporation; Exact Sciences Corporation
Recruiting - verified August 2011 - Condition: Dry Eye
Intervention: Device: 7eye( Panoptx)™ moisture chamber glasses
Sponsors: Singapore National Eye Centre; Singapore National Eye Centre
Recruiting - verified April 2011 - Conditions: Dry Eye; Sjogren's Syndrome; Graft vs. Host Disease
Intervention: Drug: Thymosin Beta 4 eye drops vs. vehicle
Sponsors: Michigan Cornea Consultants, PC; Michigan Cornea Consultants, PC; Kresge Eye Institute
Recruiting - verified July 2011 - Conditions: Haemophilia A With Inhibitors; Haemophilia B With Inhibitors
Interventions: Drug: NNC 0078-0000-0007; Drug: eptacog alfa (activated)
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Conditions: Catheter Related Infection; Bacteremia
Interventions: Other: 30 % ethanol / 4% sodium citrate catheter locking solution; Drug: Heparin 1000 u / ml
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified July 2011 - Conditions: Obesity; Morbid Obesity
Interventions: Behavioral: Experiential-Cognitive Therapy for Obesity; Behavioral: Behavioral cognitive Treatment; Dietary Supplement: Nutritional groups (NT)
Sponsors: Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Istituto Auxologico Italiano; Medica Sur Clinic & Foundation
Recruiting - verified July 2011 - Condition: Post Traumatic Stress Disorder
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS); Behavioral: Cognitive Processing Therapy; Device: Repetitive Transcranial Magnet Stimulation (rTMS)
Sponsors: The University of Texas at Dallas; The University of Texas at Dallas; Department of Defense; University of Texas Southwestern Medical Center
Recruiting - verified July 2011 - Condition: Pain Relief After Forefoot Surgery
Interventions: Procedure: Ultrasound guided ankle block; Procedure: Medial forefoot block
Sponsors: Hull and East Yorkshire Hospitals NHS Trust; Hull and East Yorkshire Hospitals NHS Trust
Recruiting - verified September 2011 - Condition: Peripheral Arterial Disease
Intervention: Drug: sodium nitrite
Sponsors: TheraVasc Inc.; TheraVasc Inc.
Recruiting - verified March 2012 - Condition: Motor Activity
Interventions: Behavioral: Motor Learning with Visual Feedback; Behavioral: Motor Learning without Visual Feedback; Behavioral: Motor Learning -- Control Group; Behavioral: Somatosensory Learning with Visual Feedback; Behavioral: Somatosensory Learning without Visual Feedback; Behavioral: Control Group - Sensory Task without Learning; Behavioral: Control Group -- no sensory or learning task; Behavioral: Observational Task; Behavioral: Control Group -- Observational Task; Behavioral: Mental Imagery; Behavioral: Control Group - Mental Imagery; Device: Transcranial Direct Current Stimulation
Sponsors: Spaulding Rehabilitation Hospital; Spaulding Rehabilitation Hospital
Recruiting - verified April 2012 - Condition: Cerebral Palsy
Interventions: Other: interactive computerized handwriting training program; Other: traditional handwriting training program
Sponsors: Chang Gung Memorial Hospital; Chang Gung Memorial Hospital
Recruiting - verified May 2011 - Condition: Opioid-Induced Constipation (OIC)
Interventions: Drug: NKTR-118; Drug: NKTR-118; Drug: Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified January 2012 - Condition: Hyponatremia.
Interventions: Drug: Tolvaptan; Other: Standard therapy
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research
Recruiting - verified September 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: olaparib; Drug: temozolomide; Genetic: gene expression analysis; Genetic: protein expression analysis; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: diffusion-weighted magnetic resonance imaging; Procedure: dynamic contrast-enhanced magnetic resonance imaging; Procedure: therapeutic conventional surgery
Sponsors: Cancer Research UK; Cancer Research UK
Recruiting - verified April 2012 - Condition: Healthy Volunteers
Interventions: Drug: OZ439; Drug: OZ439 mesylate; Drug: OZ439 mesylate; Drug: OZ439
Sponsors: Medicines for Malaria Venture; Medicines for Malaria Venture; Nucleus Network Ltd; INC Research
Recruiting - verified April 2012 - Conditions: Schizophrenia; Depression
Intervention: Device: imitation assessment using the 5-dt "data glove".
Sponsors: Shalvata Mental Health Center; Shalvata Mental Health Center
Not yet recruiting - verified December 2011 - Conditions: Mood Modulation; Modulation of Cognition
Interventions: Dietary Supplement: Hops Extract; Other: Placebo (silica)
Sponsors: Northumbria University; Northumbria University; The New Zealand Institute for Plant and Food Research
Recruiting - verified August 2011 - Conditions: Cognitive Function; Mood; Cerebral Haemodynamics; Caffeine Withdrawal
Interventions: Dietary Supplement: Placebo; Dietary Supplement: Caffeine and Placebo; Dietary Supplement: Placebo and Caffeine; Dietary Supplement: Caffeine
Sponsors: Northumbria University; Northumbria University
Recruiting - verified June 2011 - Condition: Methamphetamine Dependence
Intervention: Drug: Doxazosin extended release
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA); Baylor College of Medicine
Recruiting - verified November 2011 - Condition: Hip Fracture
Intervention: Procedure: physiotherapy
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology; Trondheim kommune, enhet for fysioterapi; Norsk kvinners sanitetsforening
Recruiting - verified September 2011 - Condition: Parkinson's Disease
Intervention: Behavioral: physical therapy
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven; University Medical Center Nijmegen
Not yet recruiting - verified June 2011 - Conditions: Social Anxiety; Schizophrenia
Interventions: Behavioral: Cognitive-Behavioral Therapy based intervention immediately; Behavioral: Wait list
Sponsors: McGill University; McGill University; Canadian Institute of Health Research Grant operating under Dr Martin Lepage
Recruiting - verified June 2011 - Conditions: Health Behavior; Personal Satisfaction
Interventions: Other: InFat™ based infant formula; Other: Standard vegetable oil based infant formula
Sponsors: Enzymotec; Enzymotec; Biostime, Inc. (Guangzhou)
Recruiting - verified January 2012 - Condition: Hepatocellular Carcinoma
Interventions: Drug: TACE-DEB; Drug: 90Y-RE
Sponsors: University Hospital, Ghent; University Hospital, Ghent
Recruiting - verified March 2012 - Conditions: Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
Interventions: Drug: Varenicline; Drug: Placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified March 2012 - Condition: Cat Allergy
Intervention: Biological: Cat-PAD
Sponsors: Circassia Limited; Circassia Limited; Adiga Life Sciences
Recruiting - verified October 2011 - Condition: Breast Lesions
Intervention:
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation
Recruiting - verified April 2012 - Conditions: Chronic Kidney Disease; Secondary Hyperparathyroidism
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Intervention: Other: observational
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified May 2011 - Condition: Gliomas
Interventions: Drug: Vorinostat; Radiation: Fractionated Stereotactic Radiosurgery (FSRT)
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Not yet recruiting - verified January 2012 - Condition: Stroke
Interventions: Other: RGRM; Other: Therapeutic riding; Other: No intervention
Sponsors: Göteborg University; Göteborg University; The Sten A Olsson foundation for Research and Culture
Recruiting - verified March 2012 - Condition: Photoaging
Interventions: Device: Harvest PRP Separation System; Other: Sterile Saline injection
Sponsors: Northwestern University; Northwestern University
Recruiting - verified June 2011 - Condition: Methamphetamine Dependence
Interventions: Other: placebo; Drug: Naltrexone and Bupropion SR
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Conditions: Acute Ischemic Stroke; Diabetes; Hyperglycemia
Interventions: Drug: IV insulin to maintain target glucose concentration of 80-130 mg/dL; Drug: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
Sponsors: University of Virginia; University of Virginia; Neurological Emergencies Treatment Trials Network (NETT); Medical University of South Carolina; Medical Automation Systems, an Alere Company; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified May 2012 - Conditions: Diabetes; Immunosuppression
Intervention: Procedure: Gastric emptying test
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; Novartis Pharmaceuticals
Recruiting - verified June 2011 - Condition: Colorectal Lesions
Interventions: Device: PillCam® COLON 2 procedure; Procedure: Colonoscopy
Sponsors: Given Imaging Ltd.; Given Imaging Ltd.
Recruiting - verified December 2011 - Condition: Methamphetamine Dependence
Intervention: Drug: Modafinil
Sponsors: California Pacific Medical Center Research Institute; California Pacific Medical Center Research Institute
Recruiting - verified January 2012 - Condition: Fragile X Syndrome
Interventions: Drug: AFQ056; Drug: AFQ056; Drug: AFQ056; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Conditions: Goiter; Hypothyroidism; Weight Gain
Intervention:
Sponsors: Naestved Hospital; Naestved Hospital; Denmark:Department of Otorhinolaryngology Slagelse Hospital, Hospital South; Denmark:Research Unit of Region Zealand, Hospital South; Denmark:Fund of Health Research, Region Zealand
Recruiting - verified April 2012 - Condition: Hepatocellular Carcinoma
Intervention: Radiation: TheraSphere
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified January 2012 - Conditions: Healthy; Thalamic Pain Syndrome; Fallers
Intervention: Other: Gait analysis
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified October 2010 - Condition: Synovial Sarcoma
Intervention: Other: NY-ESO-1 T Cells
Sponsors: University of Pennsylvania; University of Pennsylvania; Adaptimmune Ltd.; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Colon Cancer and Rectal Cancer
Intervention: Drug: E7820
Sponsors: Eisai Inc.; Eisai Inc.; PharmaBio Development Inc.
Recruiting - verified April 2012 - Condition: Spatial Neglect After Stroke
Interventions: Procedure: Prism adaptation with optical shift of 10 degrees.; Procedure: Prism adaptation optical shift of 0 degrees.
Sponsors: University Ghent; University Ghent; Fund for Scientific Research, Flanders, Belgium
Recruiting - verified April 2012 - Condition: Health Behavior
Intervention: Behavioral: Yoga Research Tool
Sponsors: University of Connecticut; University of Connecticut; National Institutes of Health (NIH); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified February 2012 - Condition: Meningitis
Interventions: Drug: Doripenem; Drug: Doripenem
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified May 2012 - Condition: Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: E7050; Drug: Cetuximab
Sponsors: Eisai Inc.; Eisai Inc.; PharmaBio Development Inc.
Recruiting - verified April 2012 - Condition: Coronary Artery Disease
Intervention: Drug: Flurpiridaz F18 Injection
Sponsors: Lantheus Medical Imaging; Lantheus Medical Imaging
Recruiting - verified April 2012 - Condition: Hepatocellular Carcinoma
Interventions: Device: HepaSphere/QuadraSphere Microspheres; Procedure: PVA, lipiodol, doxorubicin
Sponsors: Merit Medical Systems, Inc.; Merit Medical Systems, Inc.
Recruiting - verified January 2012 - Condition: Bipolar Disorder
Interventions: Drug: Lithium; Drug: Quetiapine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified April 2012 - Condition: Patent Foramen Ovale
Intervention: Device: Cardiox FDS
Sponsors: Cardiox Corporation; Cardiox Corporation
Recruiting - verified May 2012 - Condition: Fragile X Syndrome
Interventions: Drug: arbaclofen; Drug: arbaclofen; Drug: arbaclofen; Drug: Placebo
Sponsors: Seaside Therapeutics, Inc.; Seaside Therapeutics, Inc.
Recruiting - verified March 2012 - Condition: Anterior Cruciate Ligament Injury
Interventions: Procedure: Anatomic Double-Bundle ACL Reconstruction; Procedure: Anatomic Single-Bundle ACL Reconstruction
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2011 - Conditions: Sickle Cell Anemia; Sickle Cell Disease; Chronic Hemolytic Disorders
Intervention: Drug: Sodium Nitrite Cream
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Biological: SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Domestic Violence
Interventions: Behavioral: Internet-based safety decision aid; Behavioral: Usual Care Safety Plan
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute of Mental Health (NIMH); Arizona State University; University of Missouri-Columbia; Oregon Health and Science University; Kaiser Permanente
Recruiting - verified April 2012 - Condition: Lumbar Spinal Stenosis
Interventions: Device: mild® Lumbar Decompression; Drug: Epidural Steroid Injection
Sponsors: Vertos Medical, Inc.; Vertos Medical, Inc.
Recruiting - verified January 2012 - Condition: Bladder Cancer
Intervention: Behavioral: Multimodal Intervention
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital
Recruiting - verified March 2012 - Conditions: Recurrent Glioma; High-grade Meningioma; Brain Metastasis
Interventions: Drug: Panobinostat; Radiation: Stereotactic Radiosurgery
Sponsors: Thomas Jefferson University; Thomas Jefferson University; Novartis
Not yet recruiting - verified January 2012 - Conditions: Hepatoma; Liver Neoplasms; Adenoma, Liver Cell; Carcinoma, Hepatocellular
Interventions: Drug: TRC 105; Drug: Sorafenib
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: Chronic Pain
Interventions: Drug: Remifentanil; Drug: Fentanyl; Drug: Normal saline
Sponsors: University of Athens; University of Athens
Recruiting - verified March 2012 - Conditions: Advanced Prostate Cancer; Prostatic Neoplasms
Intervention: Biological: sipuleucel-T
Sponsors: Dendreon; Dendreon
Recruiting - verified March 2012 - Condition: Overactive Bladder
Interventions: Drug: Fesoterodine 8mg; Drug: Fesoterodine 4mg; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Postural Tachycardia Syndrome
Interventions: Behavioral: Seated Measurements; Behavioral: Standing Measurements; Behavioral: Self-Administered Surveys
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Warfarin Initiation
Intervention: Device: Warfarin GenoSTAT Test
Sponsors: Iverson Genetic Diagnostics, Inc.; Iverson Genetic Diagnostics, Inc.
Recruiting - verified January 2012 - Conditions: Cancer; Obesity
Interventions: Behavioral: Health Education; Behavioral: MAPS
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: HER-2 Gene Amplification
Interventions: Drug: Cisplatin, Capecitabine, Trastuzumab and MM-111; Drug: Lapatinib, Trastuzumab and MM-111; Drug: Paclitaxel, Trastuzumab and MM-111
Sponsors: Merrimack Pharmaceuticals; Merrimack Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Age-Related Macular Degeneration; Retinal Vein Occlusion; Diabetic Macular Edema
Intervention: Drug: pegaptanib sodium injection
Sponsors: Eyetech Pharmaceuticals; Eyetech Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Advanced Solid Malignant Tumors; Advanced Ovarian Cancer
Intervention: Drug: U3-1565
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified March 2012 - Condition: Tuberous Sclerosis Complex
Intervention: Drug: RAD001
Sponsors: Children's Hospital Boston; Mustafa Sahin; Tuberous Sclerosis Alliance; Autism Speaks; Novartis Pharmaceuticals; Seizure Tracker LLC
Recruiting - verified February 2012 - Condition: Crohn's Disease
Interventions: Drug: PF-04236921 SC injection; Drug: PF-04236921 SC injection; Drug: PF-04236921 SC injection; Drug: PF-04236921 SC injection
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Uterine Fibroid(s)
Intervention: Device: ExAblate UF V2
Sponsors: InSightec; InSightec
Not yet recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: irinotecan hydrochloride; Biological: bevacizumab; Biological: cetuximab; Drug: capecitabine; Genetic: mutation analysis; Genetic: gene expression analysis; Other: laboratory biomarker analysis; Other: immunohistochemistry staining method; Genetic: nucleic acid sequencing; Genetic: protein expression analysis; Genetic: polymerase chain reaction; Genetic: DNA analysis
Sponsors: Fox Chase Cancer Center; Fox Chase Cancer Center; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity
Interventions: Drug: exenatide; Drug: exenatide + exendin (9-39); Drug: placebo
Sponsors: VU University Medical Center; VU University Medical Center; Eli Lilly and Company
Recruiting - verified September 2011 - Condition: Advanced and/or Metastatic Colorectal Cancer (With Wild Type KRAS Gene)
Interventions: Drug: FOLFIRI (m); Drug: FOLFOX-6 (m); Drug: Cetuximab
Sponsors: Grupo Espanol Multidisciplinario del Cancer Digestivo; Grupo Espanol Multidisciplinario del Cancer Digestivo
Recruiting - verified January 2011 - Condition: Solid Tumors
Intervention: Drug: GO-203-2c
Sponsors: Genus Oncology, LLC; Genus Oncology, LLC
Recruiting - verified January 2012 - Condition: Fragile X Syndrome
Interventions: Drug: arbaclofen; Drug: placebo
Sponsors: Seaside Therapeutics, Inc.; Seaside Therapeutics, Inc.
Recruiting - verified March 2012 - Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107; Biological: Placebo DC
Sponsors: ImmunoCellular Therapeutics, Ltd.; ImmunoCellular Therapeutics, Ltd.
Recruiting - verified May 2012 - Condition: Age-Related Macular Degeneration
Intervention: Drug: Palomid 529
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified October 2011 - Condition: Cardiac Allograft Vasculopathy
Interventions: Biological: Rituximab induction/conventional immunosuppression (tacrolimus, MMF, and steroid taper); Drug: Rituximab placebo/conventional immunosuppression (tacrolimus, MMF, and steroid taper)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2011 - Condition: Biopsy or Ablation Procedures
Intervention:
Sponsors: Philips Healthcare; Philips Healthcare
Recruiting - verified May 2012 - Condition: Psychosis
Interventions: Behavioral: social cognitive training with in vivo augmentation; Behavioral: social cognitive training; Behavioral: non-social skills training
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint ReplacementsConditions: Edematous; Synovitis; Foreign Body Reaction; Osteolysis
Interventions: Drug: Placebo; Drug: Apatone®B
Sponsors: Summa Health System; Summa Health System; Crystal Clinic Orthopaedic Center LLC
Recruiting - verified April 2012 - Conditions: Cough; Reflux
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified July 2011 - Condition: Glaucoma
Interventions: Device: portable CCTV; Device: Telescopes, telemicroscopes and microscopes; Device: Absorptive filters
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Pfizer
Recruiting - verified August 2011 - Conditions: Crystal Methamphetamine Abuse; Crystal Methamphetamine Dependence
Interventions: Behavioral: Behavioral Activation Therapy and Risk Reduction Counseling (BAT-RR); Behavioral: Information, Motivation, Behavioral skills change approach to sexual risk reduction
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Fenway Community Health
Recruiting - verified May 2012 - Condition: Pigmented Villonodular Synovitis
Intervention: Drug: Tasigna
Sponsors: Centre Leon Berard; Centre Leon Berard; Ministry of Health, France
Recruiting - verified June 2011 - Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Nordion (Canada) Inc.
Recruiting - verified January 2012 - Conditions: Late Infantile Neuronal Ceroid Lipofuscinosis; Batten Disease
Intervention: Biological: AAVrh.10CUCLN2
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Conditions: Developmental Delay; Cerebral Palsy
Intervention: Behavioral: mobility training with dynamic body weight support
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified September 2011 - Conditions: High Risk Polycythemia Vera; High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS; Drug: Hydroxyurea; Drug: Aspirin
Sponsors: Myeloproliferative Disorders-Research Consortium; Myeloproliferative Disorders-Research Consortium; National Cancer Institute (NCI); Roche Pharma AG
Recruiting - verified December 2011 - Conditions: High Risk Polycythemia Vera; High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS; Drug: Aspirin
Sponsors: Myeloproliferative Disorders-Research Consortium; Myeloproliferative Disorders-Research Consortium; National Cancer Institute (NCI); Roche Pharma AG
Recruiting - verified February 2012 - Condition: Automobile Driving
Interventions: Drug: Zopiclone; Drug: Ethanol; Drug: Placebo pill; Drug: Placebo drink
Sponsors: St. Olavs Hospital; St. Olavs Hospital; SINTEF Health Research; Norwegian University of Science and Technology; Norwegian Institute of Public Health
Not yet recruiting - verified March 2012 - Conditions: Abnormal Mental State; Schizophrenia
Intervention: Drug: Quetiapine(Seroquel-XR) 50~800mg a day
Sponsors: Severance Hospital; Severance Hospital
Recruiting - verified November 2010 - Conditions: Cardiotoxicity; Ischemia; Heart Failure
Intervention:
Sponsors: Radboud University; Radboud University
Recruiting - verified October 2010 - Condition: Leg Spasticity
Interventions: Drug: Botulinum type A toxin (Dysport®); Drug: Placebo
Sponsors: Ipsen; Ipsen
Recruiting - verified April 2012 - Condition: Irritable Bowel Syndrome
Intervention:
Sponsors: Prometheus Laboratories; Prometheus Laboratories
Recruiting - verified November 2011 - Condition: Fragile X Syndrome
Interventions: Drug: AFQ056; Drug: AFQ056; Drug: AFQ056; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Condition: Metastatic Cancer
Intervention: Drug: ARRY-382, cFMS inhibitor; oral
Sponsors: Array BioPharma; Array BioPharma
Recruiting - verified February 2012 - Condition: Myopia
Intervention: Procedure: Switching of orthokeratology and single-vision glasses
Sponsors: The Hong Kong Polytechnic University; The Hong Kong Polytechnic University; Menicon Co., Ltd.
Recruiting - verified June 2011 - Conditions: HIV; AIDS; Substance Use Disorders
Intervention: Behavioral: Resilient Affective Processing Therapy (RAPT)
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified March 2012 - Condition: ADHD
Intervention:
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Recruiting - verified May 2012 - Condition: Claudication
Interventions: Other: Exercise Training; Other: Normal routine
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; American Heart Association; Joslin Diabetes Center
Recruiting - verified February 2012 - Condition: Blepharoptosis
Interventions: Procedure: Injection of Saline + Lidocaine/Adrenaline; Procedure: Lidocaine/Adrenaline only
Sponsors: Sheba Medical Center; Sheba Medical Center
Recruiting - verified August 2011 - Conditions: Substance-Related Disorders; Dental Caries
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified September 2010 - Condition: Traumatic Brain Injury
Interventions: Drug: Paracetamol; Drug: 0.9% Sodium Chloride Schedule:
Sponsors: South East Sydney and Illawarra Area Health Service; South East Sydney and Illawarra Area Health Service; The George Institute; The University of New South Wales; Royal Brisbane and Women's Hospital
Recruiting - verified May 2010 - Conditions: Methamphetamine-dependence; Substance Abuse
Interventions: Drug: Ibudilast; Drug: Ibudilast; Drug: Ibudilast
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Institute on Drug Abuse (NIDA); MediciNova
Recruiting - verified March 2012 - Conditions: Ischemia; Retinal Vein Occlusion; Pathologic Processes; Retinal Diseases; Eye Diseases
Intervention: Drug: ranibizumab
Sponsors: Greater Houston Retina Research; David M. Brown, M.D.; Genentech
Recruiting - verified February 2012 - Condition: Lymphoma, Mantle-Cell
Intervention: Drug: Combination of dexamethasone, ofatumumab and bendamustine
Sponsors: Southern Europe New Drug Organization; Southern Europe New Drug Organization; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting - verified September 2011 - Condition: Bronchiectasis
Intervention: Drug: Atorvastatin
Sponsors: University of Edinburgh; University of Edinburgh; NHS Lothian
Recruiting - verified November 2011 - Condition: BRONCHIECTASIS
Intervention: Drug: ATORVASTATIN
Sponsors: University of Edinburgh; University of Edinburgh; NHS Lothian
Recruiting - verified November 2011 - Condition: Adenocarcinoma of the Lung
Interventions: Biological: farletuzumab; Other: Placebo; Drug: Platinum Containing Doublet
Sponsors: Morphotek; Morphotek
Recruiting - verified May 2012 - Conditions: Colorectal Cancer; Lynch Syndrome; HNPCC
Intervention: Other: Observation
Sponsors: Vejle Hospital; Vejle Hospital
Recruiting - verified May 2012 - Condition: Osteoarthritis, Hip
Interventions: Other: Supervised progressive resistance training; Other: Control group
Sponsors: University of Aarhus; University of Aarhus; Regionshospitalet Silkeborg
Recruiting - verified November 2011 - Condition: Emergency Abdominal Surgery
Intervention: Other: Postoperative Intermediate Care
Sponsors: Copenhagen University Hospital at Herlev; Copenhagen University Hospital at Herlev; University of Copenhagen; Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Research Council Herlev University Hospital; Sygekassernes Helsefond; The Danish Council for Independent Research - Medical Sciences; AP Moeller Fundation; Hilleroed Hospital; Koege Sygehus; Bispebjerg Hospital; Herning Hospital; Aabenraa Hospital; Vejle Hospital
Recruiting - verified February 2012 - Condition: Chronic Neuropathic Pain
Interventions: Drug: Methadone; Drug: Controlled Release Morphine
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation; Dalhousie University
Not yet recruiting - verified July 2011 - Condition: Growth
Interventions: Other: Extensively hydrolyzed whey infant formula; Other: Extensively hydrolyzed casein infant formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Recruiting - verified February 2012 - Conditions: Healthy Subjects; Chronic Liver Disease; Cirrhosis
Interventions: Device: 13C Methacetin Breath Test; Dietary Supplement: Grape fruit juice; Drug: Non selective beta blocker - Propranolol; Dietary Supplement: Ethanol
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization; Exalenz Bioscience LTD.
Recruiting - verified June 2011 - Condition: Spinal Cord Injury
Intervention: Other: Exercise
Sponsors: University of Miami; University of Miami
Recruiting - verified November 2011 - Condition: Healthy Volunteers
Intervention: Other: Sucralose
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2012 - Conditions: Chronic Rhinosinusitis; Nasal Polyps
Interventions: Drug: placebo; Drug: doxycycline 100 mg
Sponsors: University Hospital, Ghent; University Hospital, Ghent
Recruiting - verified November 2011 - Conditions: Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma
Interventions: Drug: Busulfan; Drug: Fludarabine
Sponsors: West Virginia University; Mehdi Hamadani; Georgia Health Sciences University
Recruiting - verified December 2011 - Condition: Ocular Inflammation
Intervention: Drug: IBI-10090
Sponsors: ICON Bioscience Inc; ICON Bioscience Inc
Recruiting - verified March 2012 - Condition: Human Papillomavirus (HPV)
Intervention: Other: Survey
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital
Recruiting - verified July 2011 - Condition: HIV
Intervention: Behavioral: Effectiveness of different strategies in HIV testing and linkage to care
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Recruiting - verified January 2011 - Condition: GERD
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified June 2011 - Conditions: Cancer; Prevention
Interventions: Behavioral: PA Prescription Plan; Device: Pedometer; Behavioral: Newsletters
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin; Drug: Placebo matching Dapagliflozin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Recruiting - verified November 2011 - Conditions: Airway Reflexes, Protective; Recovery After Neuromuscular Block; Anesthetic Recovery
Interventions: Drug: Sevoflurane; Drug: Desflurane
Sponsors: University of California, San Francisco; University of California, San Francisco; Baxter Healthcare Corporation
Recruiting - verified March 2012 - Condition: Non-treatment Seeking Methamphetamine Users
Interventions: Drug: oral placebo and methamphetamine 20mg po; Drug: Prazosin 1mg po and oral methamphetamine placebo; Drug: Prazosin 1mg po and Methamphetamine 20mg po
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Adult; Traumatic Brain Injury; fMRI
Interventions: Other: Exercise; Other: Mood Therapy
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC); Center for Neuroscience and Regenerative Medicine (CNRM); Henry Jackson Foundation; Department of Defense
Recruiting - verified April 2012 - Condition: Hereditary Angioedema
Interventions: Drug: rhC1INH; Drug: Placebo (Saline)
Sponsors: Pharming Technologies B.V.; Pharming Technologies B.V.
Recruiting - verified April 2012 - Condition: Cataract Surgery
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified February 2012 - Condition: Metastatic Liver Disease
Intervention: Device: TheraSphere, Yttrium-90 glass Microspheres
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified January 2012 - Conditions: Atrial Fibrillation; Stroke
Interventions: Device: WATCHMAN Device; Drug: Warfarin
Sponsors: Atritech; Atritech
Recruiting - verified April 2012 - Condition: Cholestasis
Intervention: Drug: Omegaven
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati
Recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Type 2 Diabetes Mellitus
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Weill Cornell Medical College in Qatar; Hamad Medical Corporation
Recruiting - verified August 2011 - Condition: Liver Transplantation
Interventions: Drug: dipeptidyl peptidase 4 (DPP4) inhibitor; Other: oral glucose; Other: intravenous glucose
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen; University of Copenhagen
Recruiting - verified January 2012 - Condition: Presbyopia
Intervention: Device: PresVIEW Scleral Implants
Sponsors: Refocus Group, Inc.; Refocus Group, Inc.
Recruiting - verified January 2012 - Conditions: Minimal Change Disease (MCD); Membranous Nephropathy; Glomerulosclerosis, Focal Segmental
Intervention:
Sponsors: University of Michigan; University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The NephCure Foundation
Recruiting - verified March 2012 - Conditions: Myocardial Infarction; Cardiovascular Death; Atherothrombosis; Stroke
Interventions: Drug: Ticagrelor 90 mg; Drug: Ticagrelor 60 mg; Drug: Ticagrelor Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Conditions: Kidney Donation; Kidney Failure; Kidney Transplantation
Interventions: Other: Glomerular Filtration Rate with Iothalamate; Other: Glomerular Filtration Rate with Iohexol
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood Institute (NHLBI); Health Resources and Services Administration (HRSA)
Recruiting - verified February 2012 - Condition: Walking Performance
Intervention: Other: gait evaluation
Sponsors: Sheba Medical Center; Sheba Medical Center
Not yet recruiting - verified October 2011 - Condition: Schizophrenia
Interventions: Drug: amisulpride; Drug: aripiprazole
Sponsors: University of Copenhagen; University of Copenhagen; Glostrup University Hospital, Copenhagen; Rigshospitalet, Denmark; Institute of Psychiatry, London; UMC Utrecht; Copenhagen Hospital Corporation
Recruiting - verified September 2011 - Conditions: Stimulant-Related Disorders; HIV; HIV Infections
Intervention: Drug: Truvada
Sponsors: Friends Research Institute, Inc.; Friends Research Institute, Inc.; University of California, Los Angeles
Recruiting - verified October 2011 - Conditions: Pain Perception; Phlebotomy
Interventions: Drug: 4% lidocaine gel application with sham microneedle device; Drug: Microneedle-facilitated lidocaine application
Sponsors: University of Oklahoma; University of Oklahoma
Not yet recruiting - verified March 2012 - Conditions: Schizophrenia; Bipolar Disorder
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Reading Difficulty or Disability
Interventions: Drug: Methylphenidate; Behavioral: Intensive reading instruction; Behavioral: Parent Training; Drug: Mixed Salt Amphetamine; Drug: Atomoxetine; Drug: Guanfacine
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Parkinson Disease
Interventions: Other: Clinical variables; Other: Clinical variables; Other: Clinical variables
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux; Université Victor Segalen Bordeaux 2
Recruiting - verified December 2011 - Condition: Dental Caries
Interventions: Device: Fluoride Varnish; Device: Glass Ionomer Sealant
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin; Drug: Placebo matching Dapagliflozin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Recruiting - verified November 2011 - Condition: Herpes Zoster
Interventions: Biological: Zoster Vaccine Live; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Drug Abuse; HIV Risk Behavior
Interventions: Behavioral: Computerized brief intervention; Behavioral: Counselor delivered brief intervention
Sponsors: Friends Research Institute, Inc.; Friends Research Institute, Inc.; National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2011 - Conditions: HIV Medication Adherence; Methamphetamine Use; Sexual Risk; Poly-substance Use; HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training; Behavioral: Education Attention Control
Sponsors: Hunter College; Hunter College
Recruiting - verified June 2011 - Condition: Burns
Intervention: Device: ReCell and Split-thickness skin graft
Sponsors: Avita Medical Americas, LLC; Avita Medical Americas, LLC; Department of Defense; Royal Perth Hospital; MedDRA Assistance Inc; BioStat International, Inc.
Recruiting - verified February 2012 - Conditions: Substance Abuse; HIV Infections
Intervention: Behavioral: Stonewall Project
Sponsors: University of California, San Francisco; University of California, San Francisco; California HIV/AIDS Research Program
Recruiting - verified March 2012 - Condition: Incomplete Spinal Cord Injury
Interventions: Other: Locomotor training using a robotic device; Other: Locomotor training using a robotic device
Sponsors: University of Zurich; University of Zurich
Recruiting - verified April 2012 - Conditions: Cross Infection; Bacteriuria
Interventions: Dietary Supplement: cranberry type A pro anthocyandines; Dietary Supplement: Placebo
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified February 2012 - Conditions: Pediatric Cancer; Leukemia; Sarcoma; Brain Tumors
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Brain Injury
Interventions: Behavioral: Goal-based Self Management; Behavioral: Brain Health Education; Behavioral: Pathfinder Attention Process Training; Behavioral: Brain Health Education with Motor Skills Training (EDU/MOTOR); Behavioral: Tonic and Phasic Alertness Training (TAPAT); Behavioral: Object Discrimination Training (ODT)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of California, Berkeley
Recruiting - verified March 2012 - Conditions: Spondylolisthesis; Stenosis
Intervention:
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified November 2011 - Condition: Partial Supraspinatus Tear
Interventions: Biological: PRGF; Other: NACL
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Conditions: Percentage Body-Weight; Weight-Bearing Values; Weight-bearing Gait Characteristics
Intervention: Device: SmartStep insole
Sponsors: Meir Medical Center; Meir Medical Center
Available - verified January 2012 - Conditions: Hypertension, Resistant to Conventional Therapy; Atrial Fibrillation
Interventions: Procedure: Circumferential PV isolation; Procedure: Circumferential PVI+renal denervation
Sponsors: Meshalkin Research Institute of Pathology of Circulation; Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified April 2012 - Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D; Drug: Vitamin D3; Drug: Vitamin D
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat; Drug: Allopurinol
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified February 2012 - Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine Dimesylate; Drug: Atomoxetine Hydrochloride
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Congenital Diaphragmatic Hernia
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Children's Hospital Boston
Recruiting - verified February 2012 - Condition: Diarrhea Predominant Irritable Bowel Syndrome
Interventions: Drug: Asimadoline; Drug: Placebo
Sponsors: Tioga Pharmaceuticals; Tioga Pharmaceuticals; RTI Health Solutions
Recruiting - verified March 2012 - Condition: Disease, Hodgkin
Interventions: Drug: brentuximab vedotin; Drug: placebo
Sponsors: Seattle Genetics, Inc.; Seattle Genetics, Inc.; Millennium Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Conditions: Batten Disease; Late Infantile Neuronal Lipofuscinosis
Interventions: Genetic: AAVrh.10CUhCLN2 vector; Genetic: AAVrh.10CUhCLN2 vector
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention: Device: Diamondback 360 Orbital Atherecotmy System
Sponsors: Cardiovascular Systems Inc; Cardiovascular Systems Inc
Recruiting - verified March 2010 - Condition: Type 2 Diabetes
Intervention: Drug: Intensive insulin
Sponsors: Ohio University; Ohio University
Recruiting - verified July 2010 - Condition: Multiple Myeloma
Intervention: Drug: velcade
Sponsors: PETHEMA Foundation; PETHEMA Foundation
Recruiting - verified September 2011 - Condition: Respiratory Tract Infection
Intervention: Drug: clarithromycin (Klacid XL)
Sponsors: Abbott; Abbott; Eilaf CRO
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Interventions: Drug: Perindopril; Drug: Placebo; Drug: Candesartan
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Coronary Artery Disease
Interventions: Drug: RVX000222; Drug: Placebo RVX000222
Sponsors: Resverlogix Corp; Resverlogix Corp; The Cleveland Clinic
Recruiting - verified May 2012 - Conditions: Brain Tumor; Medulloblastoma; Pineoblastoma
Intervention: Radiation: proton beam radiation
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified September 2011 - Conditions: Cerebral Stroke; Cerebrovascular Accident
Interventions: Drug: Alteplase (rt-PA)/Actilyse; Procedure: Mechanic thrombectomy (MERCI, PENUMBRA, CATCH, SOLITAIRE)
Sponsors: Central Hospital, Nancy, France; Central Hospital, Nancy, France
Recruiting - verified March 2012 - Condition: Preterm Delivery
Interventions: Drug: 17-alpha-hydroxy-progesterone caproate, Makena®; Drug: Castor Oil (Placebo)
Sponsors: Obstetrix Medical Group; Obstetrix Medical Group
Recruiting - verified March 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: methylphenidate; Drug: Methylphenidate
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified January 2010 - Condition: Mild Cognitive Impairment
Intervention: Drug: Ginkgo biloba
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland
Recruiting - verified October 2011 - Condition: Healthy
Interventions: Procedure: Aspirin ingestion followed by doing a Bleeding Volume Test; Procedure: Gatorade Placebo followed by Bleeding Volume Test.
Sponsors: Klein, Jeffrey A., M.D.; Klein, Jeffrey A., M.D.
Recruiting - verified June 2011 - Condition: Osteopenia of Prematurity
Intervention: Behavioral: passive physical activity
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Conditions: Batten Disease; Late Infantile Neuronal Lipofuscinosis
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified March 2012 - Condition: Motor Activity
Intervention:
Sponsors: State University of New York - Upstate Medical University; State University of New York - Upstate Medical University
Not yet recruiting - verified November 2009 - Conditions: Neurocognitive Impairment; Acute Lymphoblastic Leukemia
Intervention: Other: Neurocognitive and behavioral evaluation
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Acute Arthritis
Intervention:
Sponsors: University Hospital, Grenoble; University Hospital, Grenoble
Recruiting - verified December 2011 - Condition: Chronic Stable Plaque Psoriasis
Interventions: Drug: Clobex Spray; Drug: Vectical Ointment; Procedure: Excimer Laser
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified January 2012 - Condition: Crying
Interventions: Other: Milk based infant formula with probiotic; Other: Milk based infant formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Recruiting - verified December 2011 - Condition: Lung Cancer
Interventions: Procedure: Cervical Mediastinoscopy; Procedure: Endobronchial Ultrasound (EBUS); Procedure: Endoscopic Ultrasound (EUS)
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Fonds de la Recherche en Santé du Québec; Society of University Surgeons; Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified November 2011 - Condition: Hemiplegia
Intervention: Device: EMS 2000
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: AMD
Interventions: Behavioral: eccentric viewing (EV) training; Device: Closed circuit television (CCTV)
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Recruiting - verified June 2011 - Condition: Amyotrophic Lateral Sclerosis
Interventions: Dietary Supplement: Oxepa; Dietary Supplement: Jevity 1.5; Dietary Supplement: Jevity 1.0
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Muscular Dystrophy Association
Recruiting - verified February 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Smoking; Smoking Cessation; Healthy Smoker; Smoker; Chronic Bronchitis; Emphysema
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Conditions: Leukemia; Acute Lymphocytic Leukemia
Interventions: Drug: Everolimus (RAD001); Drug: Cyclophosphamide; Drug: Vincristine; Drug: Doxorubicin; Drug: Dexamethasone; Drug: Mesna; Drug: Methotrexate; Drug: Ara-C (Cytarabine); Drug: Solu-Medrol; Drug: G-CSF
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Novartis
Recruiting - verified November 2011 - Condition: Liver Cancer
Interventions: Radiation: yttrium Y 90 glass microspheres; Drug: Cisplatin; Drug: Mitomycin; Drug: Doxorubicin
Sponsors: Northwestern University; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Bladder Cancer
Intervention: Drug: OGX-427
Sponsors: Vancouver Coastal Health; Vancouver Coastal Health; NCIC Clinical Trials Group; Vancouver General Hospital Foundation
Recruiting - verified February 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: Citicoline; Drug: Placebo
Sponsors: University of Utah; Perry Renshaw; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Healthy Volunteers
Intervention: Drug: buprenorphine
Sponsors: University of Zurich; University of Zurich
Recruiting - verified August 2011 - Condition: Major Depressive Disorder With Psychotic Features
Interventions: Drug: Quetiapine monotherapy; Drug: Quetiapine with SSRI
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Conditions: End Stage Renal Disease; Transplantation
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood Institute (NHLBI); Health Resources and Services Administration (HRSA)
Recruiting - verified February 2012 - Conditions: Graves Disease; Hyperthyroidism
Intervention: Drug: Potassium Iodine
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified October 2011 - Conditions: Cryptogenic Symptomatic Transient Ischemic Attack; Cryptogenic Ischemic Stroke
Intervention: Device: Reveal® XT Insertable Cardiac Monitor
Sponsors: Medtronic Cardiac Rhythm Disease Management; Medtronic Cardiac Rhythm Disease Management; Medtronic Bakken Research Center
Recruiting - verified August 2010 - Condition: Schizophrenia
Interventions: Behavioral: Brain Fitness; Behavioral: Cortex with Insight
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Condition: Bone Scan
Intervention: Other: 18F-Sodium Fluoride (Na18F)
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Cerebrovascular Accident (Stroke)
Interventions: Behavioral: Leg Exercise Program; Behavioral: Leg Management group
Sponsors: University of British Columbia; University of British Columbia; Heart and Stroke Foundation of Canada
Recruiting - verified November 2011 - Conditions: Thrombocytopenia; Acute Radiation Syndrome
Intervention: Drug: Eltrombopag
Sponsors: University of Rochester; University of Rochester
Recruiting - verified August 2011 - Conditions: Spasmodic Dysphonia; Dystonia
Intervention: Behavioral: Vocal Exercise
Sponsors: New York University School of Medicine; New York University School of Medicine; Allergan
Recruiting - verified July 2011 - Condition: Cerebral Palsy
Intervention: Other: Lokomat training
Sponsors: University Children's Hospital, Zurich; University Children's Hospital, Zurich; University Children's Hospital Basel
Recruiting - verified December 2011 - Condition: Stroke
Interventions: Drug: Tissue Plasminogen Activator (Alteplase); Drug: Placebo
Sponsors: National Stroke Research Institute, Australia; National Stroke Research Institute, Australia; Commonwealth Scientific & Industry Research Organisation; Brain Research Institute; University of Melbourne; Melbourne Health
Recruiting - verified May 2012 - Conditions: Liver Tumors; Hepatocellular Carcinoma; Hepatoma; Neoplasms
Intervention: Device: TheraSphere®
Sponsors: St. Joseph Hospital of Orange; St. Joseph Hospital of Orange
Recruiting - verified March 2012 - Condition: Cardiac Arrest
Interventions: Procedure: Therapeutic Hypothermia; Procedure: Therapeutic Normothermia
Sponsors: University of Michigan; University of Michigan; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011 - Condition: Cardiac Arrest
Interventions: Procedure: Therapeutic Hypothermia; Other: Therapeutic Normothermia
Sponsors: University of Michigan; University of Michigan; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011 - Condition: Ischemic Stroke
Interventions: Drug: donepezil; Drug: placebo
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Pulmonary Tuberculosis
Intervention: Drug: Moxifloxacin,Ethambutol,Isoniazid,Pyrazinamide & Rifampicin
Sponsors: University College, London; University College, London; European and Developing Countries Clinical Trials Partnership (EDCTP); Global Alliance for TB Drug Development; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma; Sanofi-Aventis; Svizera Labs, Almere, Netherlands
Recruiting - verified January 2012 - Conditions: Leukemia, Myeloid, Acute; Acute Lymphoblastic Leukemia; Myelodysplasia; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin
Intervention: Drug: Sitagliptin
Sponsors: Indiana University; Indiana University School of Medicine
Recruiting - verified May 2012 - Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine; Drug: Daunorubicin; Drug: Prednisone; Drug: Mitoxantrone; Drug: Cytosine Arabinoside; Drug: Dexamethasone; Drug: Methotrexate (MTX); Drug: Cytarabine; Drug: ASP; Drug: Mercaptopurine; Drug: Teniposide; Drug: Hydrocortisone
Sponsors: PETHEMA Foundation; PETHEMA Foundation
Recruiting - verified December 2011 - Condition: Bone Neoplasm
Interventions: Device: Bioactive glass granules (Bonalive); Device: Beeta-tricalcium phosphate (ChronOs); Procedure: Autograft; Procedure: Allograft (frozen femoral head)
Sponsors: Turku University Hospital; Turku University Hospital
Recruiting - verified June 2011 - Condition: Hip Fracture
Interventions: Other: Basic mobility; Other: training of knee-extension strength
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital
Not yet recruiting - verified March 2012 - Conditions: Acute Myelocytic Leukemia; Acute Lymphocytic Leukemia; Chronic Myelocytic Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic Syndromes
Intervention: Drug: ON 01910.Na
Sponsors: Onconova Therapeutics, Inc.; Onconova Therapeutics, Inc.
Recruiting - verified January 2012 - Condition: Brain Metastases
Interventions: Drug: Vorinostat; Radiation: Radiation Therapy
Sponsors: Thomas Jefferson University; Thomas Jefferson University; Merck
Recruiting - verified January 2012 - Condition: Cancer
Interventions: Behavioral: Questionnaire; Other: Body Measurements; Behavioral: Self-help Materials
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: Congestive Heart Failure
Intervention: Device: CRT Therapy - LV Lead Registry
Sponsors: Biotronik, Inc.; Biotronik, Inc.
Recruiting - verified May 2012 - Condition: Andropause
Intervention: Drug: AndroGel® (testosterone gel)
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Aging (NIA); National Institute of Neurological Disorders and Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Heart, Lung, and Blood Institute (NHLBI); Abbott
Recruiting - verified January 2012 - Conditions: Fuchs' Endothelial Corneal Dystrophy; Bullous Keratopathy; Iridocorneal Endothelial Syndrome; Posterior Polymorphous Dystrophy
Intervention: Procedure: endothelial keratoplasty
Sponsors: Cornea Research Foundation of America; Cornea Research Foundation of America
Recruiting - verified November 2011 - Condition: Hematoma
Interventions: Drug: low molecular weight heparin or unfractionated heparin; Drug: Warfarin or coumadin
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Conditions: Binocular Dysfunction; Vertical Heterophoria; Vision, Binocular; Vision Disparity
Interventions: Device: Lenses containing prismatic correction; Device: Lenses not containing prismatic correction
Sponsors: Vision Specialists of Birmingham; Vision Specialists of Birmingham; Essilor International
Recruiting - verified April 2012 - Conditions: Cocaine Dependence; Cocaine-Related Disorders; Opioid-Related Disorders
Interventions: Drug: Airipiprazole; Drug: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2011 - Condition: Stroke
Interventions: Behavioral: APA-Stroke; Behavioral: Sittercize
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Maryland; Howard County Office on Aging; National Rehabilitation Hospital
Recruiting - verified November 2011 - Conditions: Acute Myocardial Infarction (AMI); Coronary Occlusion; Acute Coronary Syndrome
Intervention: Device: AngelMed Guardian System
Sponsors: Angel Medical Systems; Angel Medical Systems; Symbios Clinical
Recruiting - verified April 2012 - Condition: Prostate Cancer
Interventions: Drug: Androgen Deprivation Therapy; Drug: bicalutamide; Drug: bevacizumab
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute; Genentech; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Cancer Institute of New Jersey
Recruiting - verified February 2012 - Conditions: Deep Vein Thrombosis; Venous Thrombosis; Postphlebitic Syndrome; Venous Thromboembolism; Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
Sponsors: Washington University School of Medicine; Washington University School of Medicine; McMaster University; Ontario Clinical Oncology Group (OCOG); National Heart, Lung, and Blood Institute (NHLBI); Bacchus Vascular; BSN Medical Inc; Genentech; MEDRAD Interventional/Possis; Mid America Heart Institute; Society of Interventional Radiology Foundation; Massachusetts General Hospital
Recruiting - verified May 2012 - Condition: Degenerative Disc Disease (DDD)
Interventions: Device: FLD; Device: Control
Sponsors: AxioMed Spine Corporation; AxioMed Spine Corporation
Recruiting - verified January 2012 - Condition: Osteoarthritis
Interventions: Dietary Supplement: Essential amino acids; Dietary Supplement: Alanine
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2012 - Condition: Prostatic Neoplasms
Intervention:
Sponsors: University of Washington; University of Washington; Canary Foundation; Early Detection Research Network
Recruiting - verified June 2011 - Condition: Stroke
Interventions: Other: Surface functional electrical stimulation (FES) assisted movement training; Other: Motor learning; Other: Brain computer interface (BCI) training
Sponsors: Louis Stokes VA Medical Center; National Institute of Neurological Disorders and Stroke (NINDS); Louis Stokes VA Medical Center
Recruiting - verified July 2011 - Condition: Suspected Eosinophilic Esophagitis
Intervention: Procedure: Esophageal dilation
Sponsors: Vanderbilt University; Vanderbilt University; Takeda Global Research & Development Center, Inc.
Recruiting - verified July 2011 - Conditions: Leukemia; Myelodysplastic Syndrome; Non-Hodgkins Lymphoma; Chronic Myelogenous Leukemia
Intervention: Other: fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified January 2012 - Condition: Male Fertility
Intervention:
Sponsors: Lotus Bio Inc.; Lotus Bio Inc.
Not yet recruiting - verified June 2011 - Conditions: Human Papilloma Virus; HPV; Post Partum
Intervention:
Sponsors: Columbia University; Columbia University; Merck
Recruiting - verified February 2012 - Conditions: Sudden Cardiac Death; Acute Myocardial Infarction
Intervention: Other: Blood sample
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified July 2011 - Condition: Breast Cancer
Interventions: Drug: PD 0332991; Drug: letrozole; Drug: letrozole
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Stroke
Interventions: Drug: Sinemet, ritalin, amphetamine, and placebo; Device: Transcranial magnetic stimulation (TMS); Other: Combined drug treatment and TMS
Sponsors: Emory University; Emory University; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2012 - Conditions: Substance Abuse; HIV Infections
Interventions: Behavioral: contingency management; Behavioral: contingency management
Sponsors: University of Connecticut Health Center; University of Connecticut Health Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Conditions: Heroin Dependence; Opioid-Related Disorders; Cocaine Abuse or Dependence
Intervention:
Sponsors: Wayne State University; Wayne State University; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Condition: Schizophrenia
Interventions: Behavioral: Neuroadaptive cognitive training; Behavioral: Computer games
Sponsors: University of California, San Francisco; University of California, San Francisco; Stanley Medical Research Institute
Recruiting - verified March 2012 - Conditions: Lumbar Spinal Stenosis; Neurogenic Intermittent Claudication
Interventions: Device: Superion™ Interspinous Spacer; Device: X-STOP® IPD® Device
Sponsors: VertiFlex, Incorporated; VertiFlex, Incorporated
Recruiting - verified November 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Supplemental oxygen therapy
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); Centers for Medicare and Medicaid Services
Recruiting - verified April 2012 - Condition: Psoriasis
Interventions: Procedure: Narrow band (310-312 nm) ultraviolet light B phototherapy; Drug: etanercept
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified February 2012 - Condition: Joint Disease
Interventions: Procedure: LRTI; Procedure: Ascension PyroDisk
Sponsors: Simon Fraser Orthopaedic Fund; Simon Fraser Orthopaedic Fund
Recruiting - verified June 2011 - Conditions: Lung Neoplasm; Carcinoma Non-small Cell Lung Cancer Stage IIIA; Carcinoma Non-small Cell Lung Cancer Stage IIIB; Carcinoma Non-small Cell Lung Cancer Stage IV
Interventions: Biological: Lucanix™; Other: Placebo Comparator
Sponsors: NovaRx Corporation; NovaRx Corporation
Recruiting - verified April 2012 - Condition: Macular Degeneration
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified November 2011 - Condition: Traumatic Brain Injury
Interventions: Procedure: body weight supported treadmill training; Procedure: traditional physical therapy
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Condition: Schizophrenia
Interventions: Behavioral: Neuroadaptive cognitive training; Behavioral: Computer games
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Obsessive-Compulsive Disorder
Intervention: Device: Deep brain stimulation (DBS)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Conditions: Psychotic Depression; Major Depression With Psychotic Features; Psychosis
Interventions: Drug: mifepristone; Drug: placebo
Sponsors: Corcept Therapeutics; Corcept Therapeutics
Recruiting - verified February 2012 - Conditions: Neurofibromatosis Type 1; Reading Disabilities
Interventions: Behavioral: Tutoring Program I; Behavioral: Tutoring Program II
Sponsors: Vanderbilt University; Vanderbilt University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified June 2011 - Condition: Metastatic Epidural Spinal Cord Compression
Interventions: Procedure: Surgical excision of the metastatic process; Radiation: Radiotherapy of the metastatic spine process
Sponsors: AO Clinical Investigation and Documentation; AO Clinical Investigation and Documentation; AOSpine North America
Recruiting - verified November 2011 - Conditions: Intracranial Aneurysm; Subarachnoid Hemorrhage
Intervention: Procedure: endovascular coil embolization
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified January 2012 - Conditions: Soft Tissue Sarcoma; Osteosarcoma
Intervention:
Sponsors: State University of New York - Upstate Medical University; State University of New York - Upstate Medical University; Huntsman Cancer Institute
Recruiting - verified August 2010 - Condition: Liver Cancer
Interventions: Radiation: brachytherapy; Radiation: yttrium Y 90 glass microspheres
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Spinal Cord Disease; Intracranial Central Nervous System Disorder; Neurologic Disorders; Brain Neoplasms
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified November 2011 - Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension; PAH WHO Group I
Interventions: Drug: Sitaxsentan; Drug: Bosentan, Ambrisentan
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System; National Institutes of Health (NIH); Baylor College of Medicine; Emory University; University of Chicago; Johns Hopkins University; Tufts Medical Center; Sir Mortimer B. Davis - Jewish General Hospital; London Health Sciences Centre; University of Maryland; University of California, San Francisco; University of Calgary; Chest Medical Associates; Columbia University; Lung Diagnostics, Ltd.; Duke University; University of California, Los Angeles; Latter Day Saints Hospital; Louisiana State University Health Sciences Center in New Orleans; Massachusetts General Hospital; Mayo Clinic; Medical College of Wisconsin; Southeastern Lung Care; Suncoast Lung Center; Children's Hospital Colorad; University Hospitals of Cleveland; University of Colorado, Denver; University of Michigan; University of Pittsburgh; University of Southern California; The University of Texas, Galveston; Vanderbilt University; Wayne State University; Ohio State University; University of Alabama at Birmingham; Washington University School of Medicine; Sentara Norfolk General Hospital; University of Texas Southwestern Medical Center; Bay Area Chest Physicians
Recruiting - verified January 2012 - Condition: Parkinson's Disease
Intervention: Behavioral: Exercise - Progressive resistance and flexibility training
Sponsors: University of Illinois; University of Illinois; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified August 2011 - Condition: Pancreatitis
Interventions: Procedure: Naso jejunal feeding tube insertion; Procedure: NG feeding tube insertion
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified August 2011 - Condition: Breast Cancer
Intervention: Other: perform dynamic contrast enhanced (DCE) MRI
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Oregon Health and Science University; DeltaPoint,Inc.
Recruiting - verified December 2011 - Conditions: Hemiplegia; Stroke
Interventions: Other: Muscular Strengthening for paretic knee flexor and extensor; Other: conventional physiotherapy
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse; University Hospital, Bordeaux; University Hospital, Limoges
Recruiting - verified September 2011 - Conditions: Adult Attention Deficit Hyperactivity Disorder; Cocaine Dependence
Interventions: Drug: Placebo; Drug: Adderall-XR; Drug: Adderall-XR
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine; Drug: Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Liver Cancer; Metastatic Cancer
Intervention: Radiation: Yttrium Y 90 glass microspheres
Sponsors: Northwestern University; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Cataract
Intervention: Device: OCT measurements
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Eye Institute (NEI)
Recruiting - verified May 2012 - Condition: Liver Cancer
Intervention: Radiation: yttrium Y 90 glass microspheres
Sponsors: Northwestern University; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Weill Cornell Medical College in Qatar; Hamad Medical Corporation
Recruiting - verified August 2011 - Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Atopic Dermatitis
Intervention:
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified March 2012 - Condition: Obsessive Compulsive Disorder
Intervention: Drug: Duloxetine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eli Lilly and Company
Recruiting - verified July 2011 - Condition: Coronary Artery Disease
Interventions: Procedure: Robotic-assisted Coronary Surgical Revascularization; Procedure: PCI- Drug Eluting Stents
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Canada Foundation for Innovation; Ontario Innovative Trust; Ontario Research and Development Challenge Fund
Recruiting - verified August 2011 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Klinefelter Syndrome
Interventions: Drug: androgen oxandrolone; Other: placebo
Sponsors: Thomas Jefferson University; Thomas Jefferson University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified July 2011 - Conditions: Arthritis, Rheumatoid; Osteoarthritis
Interventions: Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen
Sponsors: Pfizer; Pfizer; The Cleveland Clinic
Recruiting - verified May 2012 - Condition: Pulmonary Diseases
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Melanoma
Interventions: Procedure: Completion Lymphadenectomy; Procedure: Monitoring with nodal ultrasound
Sponsors: John Wayne Cancer Institute; John Wayne Cancer Institute; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Condition: Myasthenia Gravis
Interventions: Procedure: thymectomy; Drug: prednisone
Sponsors: University of Alabama at Birmingham; Gary Cutter, PhD; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified October 2011 - Condition: Burn
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Shriners Hospitals for Children
Recruiting - verified May 2012 - Conditions: Brain Diseases, Metabolic, Inborn; Amino Acid Metabolism, Inborn Errors; Urea Cycle Disorders
Intervention:
Sponsors: Children's Research Institute; Children's Research Institute; National Center for Research Resources (NCRR); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Conditions: Common Childhood Illnesses; Non-emergent Care
Intervention: Procedure: Health-e-Access
Sponsors: University of Rochester; University of Rochester; United States Department of Commerce; Robert Wood Johnson Foundation
Recruiting - verified October 2005 - Conditions: Smoking; Lung Diseases
Interventions: Procedure: Bronchopulmonary Lung Lavage; Procedure: Bronchial Brushing; Procedure: Bronchial Wall Biopsy
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Institute of Genetic Medicine; New York Presbyterian Hospital; Rockefeller University
Recruiting - verified August 2011 - Conditions: Lung Disease; Bronchitis; Emphysema; COPD; Asthma
Interventions: Procedure: Bronchopulmonary Lung Lavage; Procedure: Bronchial Brushing; Procedure: Bronchial Wall Biopsy
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Fetal Membranes, Premature Rupture
Interventions: Procedure: Retention of Cerclage; Procedure: Removal of Cerclage; Procedure: Removal vs. Retention of Cervical Cerclage
Sponsors: Obstetrix Medical Group; Obstetrix Medical Group
Recruiting - verified March 2012 - Condition: Nervous System Diseases
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified June 2011 - Conditions: Retinitis Pigmentosa Syndromic; Congenital Deafness; Usher Syndrome; Retinitis Pigmentosa and Deafness; Progressive Hearing Loss; Retinitis Pigmentosa
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified July 2011 - Conditions: Stroke; Myocardial Infarction; Diabetes
Interventions: Drug: pioglitazone; Drug: placebo
Sponsors: Yale University; Yale University; National Institute of Neurological Disorders and Stroke (NINDS); Takeda Pharmaceuticals North America, Inc.
Recruiting - verified August 2011 - Condition: Neoplasm
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified June 2011 - Conditions: Healthy; Helminthiasis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Cystinosis
Intervention: Drug: Cysteamine
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified November 2011 - Conditions: Ewing's Sarcoma; Leukemia; Lymphoma; Neoplasm; Sarcoma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified July 2011 - Conditions: Healthy; Inflammation; Vasculitis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011
 |
Join Clinical Trials for Methamphetamine Addiction, and Other Types of Addictions |
